Spiperone

CAS No. 749-02-0

Spiperone( Spiperone | E 525 | E-525 | E525 | R 5147 | R-5147 | R5147 | NSC 170983 )

Catalog No. M15854 CAS No. 749-02-0

A spiro butyrophenone analog similar to HALOPERIDOL and other related compounds. It has been recommended in the treatment of SCHIZOPHRENIA.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 35 In Stock
10MG 52 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Spiperone
  • Note
    Research use only, not for human use.
  • Brief Description
    A spiro butyrophenone analog similar to HALOPERIDOL and other related compounds. It has been recommended in the treatment of SCHIZOPHRENIA.
  • Description
    A spiro butyrophenone analog similar to HALOPERIDOL and other related compounds. It has been recommended in the treatment of schizophrenia.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Spiperone | E 525 | E-525 | E525 | R 5147 | R-5147 | R5147 | NSC 170983
  • Pathway
    GPCR/G Protein
  • Target
    Dopamine Receptor
  • Recptor
    Dopamine
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    749-02-0
  • Formula Weight
    395.47
  • Molecular Formula
    C23H26FN3O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 10 mM
  • SMILES
    O=C1NCN(C2=CC=CC=C2)C13CCN(CCCC(C4=CC=C(F)C=C4)=O)CC3
  • Chemical Name
    8-(4-(4-fluorophenyl)-4-oxobutyl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Zheng LT, et al.J Neurochem. 2008 Dec;107(5):1225-35.
molnova catalog
related products
  • Syrosingopine

    Syrosingopine has selective depleting effect on brain amines is potentiated by combined treatment with disulfiram or fusaric acid, a dopamine beta-hydroxylase inhibitor.

  • JNJ-37822681

    JNJ-37822681 is a novel, highly selective dopamine D? receptor antagonist characterized by a rapid dissociation rate from the dopamine D? receptor.

  • GSK598809

    GSK598809 (GSK-598809) is a potent, selective, CNS penetrant and orally bioavailable dopamine D3 receptor antagonist with pKi of 8.9; displays >100-fold selectivity over D2 and H1 receptors.